LTRN READ THE FULL LTRN RESEARCH REPORT Lantern Pharma, Inc (NASDAQ:LTRN) reports 2024 results highlighting several ...

Infineon CEO Jochen Hanebeck on protectionist policies' impact on semiconductors, highlighting India's role in chip design ...

With Lego Ideas, anything is possible. Right now, there are a tonne of Lego Ideas projects paying homage to the great Hayo ...

Q4 2024 Earnings Call Transcript March 27, 2025 Innate Pharma S.A. misses on earnings expectations. Reported EPS is $-0.33474 ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class i targeted and immune-mediated therapeutics to fight cancer, today announced that an ...

BioAtla is extending its runway beyond key clinical readouts in 1H 2026 by restructuring and realigning resources, which ...

Tempest Therapeutics is a clinical-stage biotechnology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the ...

Four local emerging artists have been awarded $2000 each in the 2025 Create Lab small grants program to explore a creative ...

Novel trispecific T cell engager, ZW209, demonstrates potent preclinical efficacy against DLL3-expressing tumors and an encouraging safety ...

Q4 2024 Earnings Conference Call March 27, 2025 4:30 PM ETCompany ParticipantsBruce Mackle - LifeSci Advisors, ...

For almost half a decade, the MacBook Air hasn't just sold well; it's been the best-selling single laptop model on the planet ...